NEUROTEX LIMITED

No Analysis Available

Get instant AI-powered insights about this company's financial health, risks, and trends.

Order Analysis - £10
Legal registered address
C/O OXFORD BIOMATERIALS LTD. MAGDALEN CENTRE ROBERT ROBINSON AVENUE OXFORD OX4 4GA Copied!

Latest financial results as of 7 September 2025
Current assets
£7.25k
Current creditors
£1.50k
Shareholders funds
£5.75k
View full financial accounts

Company number
05842082 Copied!
Company status
Active
Company type
Private Limited Company
Incorporated on
9 June 2006
Accounts

Latest annual accounts were to 31 July 2020

Next annual accounts are due by 30 April 2022

Company financial year end is on 31 July 2026

Confirmation statement

Latest confirmation statement statement dated 25 April 2020

Next statement due by 9 May 2021

Nature of business (SIC)

72190 - Other research and experimental development on natural sciences and engineering

Latest company documents
DateDescription
04/09/204 September 2020 MICRO COMPANY ACCOUNTS MADE UP TO 31/07/20

View Document

31/07/2031 July 2020 Annual accounts for year ending 31 Jul 2020

View Accounts

30/04/2030 April 2020 CONFIRMATION STATEMENT MADE ON 25/04/20, NO UPDATES

View Document

10/01/2010 January 2020 MICRO COMPANY ACCOUNTS MADE UP TO 31/07/19

View Document

31/07/1931 July 2019 Annual accounts for year ending 31 Jul 2019

View Accounts

View all company documents
AI-Powered Analysis for NEUROTEX LIMITED

Get instant insights with Claude AI. Ask questions like:

  • "Is NEUROTEX LIMITED financially stable?"
  • "What are the key risks for lending to this company?"
  • "Show me the director history and red flags"
Set Up AI Assistant

Takes 60 seconds • Works with Claude.ai


More Company Information

AI Company Analysis

Ask Claude AI about NEUROTEX LIMITED:


Start Free Setup →

No downloads • 60 second setup


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company